Salem Investment Counselors Inc Gilead Sciences, Inc. Transaction History

Salem Investment Counselors Inc

  • $3.24 Billion
  • Q3 2024

A detailed history of Salem Investment Counselors Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Salem Investment Counselors Inc holds 607 shares of GILD stock, worth $54,107. This represents 0.0% of its overall portfolio holdings.

Number of Shares
607
Previous 607 -0.0%
Holding current value
$54,107
Previous $41,000 21.95%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 11, 2024
SELL
$71.58 - $87.29 $28,488 - $34,741
-398 Reduced 39.6%
607 $44,000
Q4 2023

Jan 16, 2024
SELL
$73.27 - $83.09 $4,762 - $5,400
-65 Reduced 6.07%
1,005 $81,000
Q2 2023

Jul 19, 2023
BUY
$76.01 - $86.7 $15,049 - $17,166
198 Added 22.71%
1,070 $82,000
Q1 2023

May 11, 2023
BUY
$77.31 - $88.08 $27,058 - $30,828
350 Added 67.05%
872 $72,000
Q4 2022

Feb 15, 2023
SELL
$62.32 - $89.47 $1,869 - $2,684
-30 Reduced 5.43%
522 $44,000
Q3 2022

Nov 09, 2022
BUY
$59.54 - $68.01 $1,786 - $2,040
30 Added 5.75%
552 $34,000
Q1 2022

May 16, 2022
BUY
$57.92 - $72.58 $1,274 - $1,596
22 Added 4.4%
522 $31,000
Q1 2021

May 17, 2021
SELL
$60.0 - $68.46 $4,260 - $4,860
-71 Reduced 12.43%
500 $32,000
Q4 2020

Feb 17, 2021
BUY
$56.65 - $64.55 $4,022 - $4,583
71 Added 14.2%
571 $33,000
Q2 2020

Aug 13, 2020
SELL
$72.34 - $84.0 $49,552 - $57,540
-685 Reduced 57.81%
500 $38,000
Q1 2020

May 14, 2020
BUY
$62.63 - $80.22 $35,385 - $45,324
565 Added 91.13%
1,185 $89,000
Q4 2019

Feb 13, 2020
SELL
$61.62 - $67.78 $27,729 - $30,501
-450 Reduced 42.06%
620 $40,000
Q2 2019

Aug 14, 2019
SELL
$61.87 - $69.38 $99,920 - $112,048
-1,615 Reduced 60.15%
1,070 $72,000
Q1 2019

May 15, 2019
BUY
$62.53 - $70.05 $167,893 - $188,084
2,685 New
2,685 $207,000
Q4 2018

Feb 15, 2019
SELL
$60.54 - $79.0 $162,549 - $212,115
-2,685 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$71.28 - $78.92 $10,478 - $11,601
-147 Reduced 5.19%
2,685 $207,000
Q2 2018

Aug 15, 2018
SELL
$64.88 - $75.68 $4.22 Million - $4.93 Million
-65,100 Reduced 95.83%
2,832 $201,000
Q1 2018

May 15, 2018
SELL
$72.84 - $88.8 $272,057 - $331,668
-3,735 Reduced 5.21%
67,932 $4.99 Million
Q4 2017

Feb 16, 2018
SELL
$71.15 - $83.52 $1.51 Million - $1.77 Million
-21,230 Reduced 22.85%
71,667 $5.13 Million
Q3 2017

Nov 16, 2017
BUY
$72.11 - $85.47 $6.7 Million - $7.94 Million
92,897
92,897 $7.69 Million

Others Institutions Holding GILD

# of Institutions
1,930
Shares Held
992M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $112B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Salem Investment Counselors Inc Portfolio

Follow Salem Investment Counselors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Salem Investment Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Salem Investment Counselors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email